Rho‐associated protein kinase 2 (ROCK2) is an important therapeutic target, and its upregulation was confirmed in many cancers, including T‐cell acute lymphoblastic leukemia (T‐ALL) [62, 63]. The gene discussed is ROCK2; the disease is acute lymphoblastic leukemia.